Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × ulocuplumab × Clear all

NCT01120457 2015-03-06

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute